Scholarly Works

In symptomatic peripheral artery disease with T2D,...

Journal article

In symptomatic peripheral artery disease with T2D, semaglutide increased maximum walking distance at 1 y.

Abstract

CLINICAL IMPACT RATINGS: GIM/FP/GP: [Formula: see text] Cardiology: [Formula: see text] Endocrinology: [Formula: see text].

Authors

Ades M; Anand SS

Journal

Annals of Internal Medicine, Vol. 178, No. 9,

Publisher

American College of Physicians

Publication Date

September 1, 2025

DOI

10.7326/annals-25-03196-jc

ISSN

1056-8751

Associated Experts

Sonia Anand

Professor, Faculty of Health Sciences

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences 3202 Clinical Sciences

Sustainable Development Goals (SDG)

3 Good Health and Well Being

Medical Subject Headings (MeSH)

Humans Peripheral Arterial Disease Glucagon-Like Peptides Male Female Walking Diabetes Mellitus, Type 2 Middle Aged Hypoglycemic Agents Aged Glucagon-Like Peptide 1

View published work (Non-McMaster Users)

View published work (McMaster Users)

Contact the Experts team

Get technical help

or

Provide website feedback